Central neurotoxicity of immunomodulatory drugs in multiple myeloma
Immunomodulatory drugs (IMiDs) currently used in the treatment of multiple myeloma, are thalidomide, lenalidomide and pomalidomide. One of the most common side effects of thalidomide is neurotoxicity, predominantly in the form of peripheral neuropathy. We report 6 cases of significant central neurot...
| 主要な著者: | , , , , , |
|---|---|
| フォーマット: | 論文 |
| 言語: | English |
| 出版事項: |
MDPI AG
2015-03-01
|
| シリーズ: | Hematology Reports |
| 主題: | |
| オンライン･アクセス: | http://www.pagepress.org/journals/index.php/hr/article/view/5704 |